Parmax Pharma Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 1.95 | 4.73 | 6.30 |
| Operating Expense | 2.19 | 6.46 | 6.18 |
| Net Profit | -0.76 | -1.49 | -0.39 |
| Net Profit Margin | -38.97 | -31.50 | -6.19 |
| Earning Per Share | -2.04 | -4 | -1.05 |
| EBIDTA | -0.24 | -1.43 | 0.13 |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 1.95 |
| Operating Expense | 2.19 |
| Net Profit | -0.76 |
| Net Profit Margin | -38.97 |
| Earning Per Share | -2.04 |
| EBIDTA | -0.24 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 28.20 | 11.05 | 15.42 |
| Operating Expenses Annual | 27.95 | 14.42 | 13.17 |
| Operating Profit Annual | -0.78 | -3.32 | 2.29 |
| Interest Annual | 0.59 | 0.62 | 0.37 |
| Depreciation | 1.03 | 1.71 | 1.88 |
| Net Profit Annual | -2.09 | -5.75 | -0.10 |
| Tax Annual | -0.30 | 0.09 | 0.15 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 28.20 |
| Operating Expenses Annual | 27.95 |
| Operating Profit Annual | -0.78 |
| Interest Annual | 0.59 |
| Depreciation | 1.03 |
| Net Profit Annual | -2.09 |
| Tax Annual | -0.30 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.05 | 0.41 | 1.05 |
| Cash Flow from Operations | -0.96 | -0.20 | 0.33 |
| Cash Flow from Investing | -0.70 | -1.59 | -0.94 |
| Cash Flow from Financing | 1.40 | 1.43 | -0.04 |
| Cash Flow at the End | -0.21 | 0.05 | 0.41 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 0.05 |
| Cash Flow from Operations | -0.96 |
| Cash Flow from Investing | -0.70 |
| Cash Flow from Financing | 1.40 |
| Cash Flow at the End | -0.21 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 1.06 | -30.05 | 14.85 |
| PBIT Margin (%) | -2.59 | -45.52 | 2.66 |
| PBT Margin (%) | 1.81 | 28.05 | -4.73 |
| Net PROFIT Margin (%) | -7.41 | -52.04 | -0.65 |
| Return On Networth / Equity (%) | TBA | TBA | -1.69 |
| Return On Networth /Employed (%) | TBA | TBA | 3.76 |
| Return On Assets (%) | -35.65 | -66.61 | -0.89 |
| Total Debt / Equity (X) | TBA | 1.90 | 0.89 |
| Asset Turnover Ratio (%) | 4.81 | 1.28 | 1.38 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 1.06 |
| PBIT Margin (%) | -2.59 |
| PBT Margin (%) | 1.81 |
| Net PROFIT Margin (%) | -7.41 |
| Return On Networth / Equity (%) | TBA |
| Return On Networth /Employed (%) | TBA |
| Return On Assets (%) | -35.65 |
| Total Debt / Equity (X) | TBA |
| Asset Turnover Ratio (%) | 4.81 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 7.97 | 9.27 | 9.50 |
| Total Current Assets Annual | 10.00 | 5.77 | 7.53 |
| Non Current Assets Annual | 8.75 | 9.56 | 10.08 |
| Total Shareholders Funds Annual | -1.99 | 0.11 | 5.86 |
| Total Assets Annual | 18.75 | 15.33 | 17.61 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 7.97 |
| Total Current Assets Annual | 10.00 |
| Non Current Assets Annual | 8.75 |
| Total Shareholders Funds Annual | -1.99 |
| Total Assets Annual | 18.75 |
No Data Availabe
